STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 98 filers reported holding STOKE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.06 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $5,664,514 | +12.7% | 532,880 | -11.7% | 0.17% | +13.7% |
| Q1 2023 | $5,027,355 | -1.0% | 603,524 | +9.7% | 0.15% | -1.3% |
| Q4 2022 | $5,078,521 | +52.7% | 550,219 | +112.4% | 0.16% | +42.2% |
| Q3 2022 | $3,326,000 | +26.8% | 259,014 | +30.4% | 0.11% | +21.1% |
| Q2 2022 | $2,624,000 | – | 198,621 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skorpios Trust | 14,443,681 | $153,536,329 | 66.66% |
| M28 Capital Management LP | 346,190 | $3,680,000 | 4.86% |
| COWEN AND COMPANY, LLC | 3,721,659 | $39,561,235 | 3.28% |
| Redmile Group, LLC | 3,955,188 | $42,043,648 | 1.61% |
| RTW INVESTMENTS, LP | 4,390,558 | $46,671,632 | 0.89% |
| Birchview Capital, LP | 85,000 | $903,550 | 0.68% |
| Cormorant Asset Management, LP | 1,087,807 | $11,563,388 | 0.65% |
| Ikarian Capital, LLC | 215,200 | $2,287,576 | 0.36% |
| Octagon Capital Advisors LP | 185,669 | $1,973,661 | 0.28% |
| Granahan Investment Management | 532,880 | $5,664,514 | 0.17% |